患者报告疼痛的动态变化与转移性去势敏感性前列腺癌生存的关联——LATITUDE研究探索性分析
该研究为LATITUDEⅢ期随机研究的探索性分析,纳入1125例至少完成3次疼痛评分测量的转移性去势敏感性前列腺癌(mCSPC)患者,采用贝叶斯联合模型分析疼痛最重评分(WPS)和疼痛干扰评分(PIS)的动态变化与总生存(OS)及无进展生存(PFS)的关联。结果显示,当前WPS每增加1单位与OS较差(HR 1.316)和PFS较差(HR 1.319)相关,当前PIS每增加1单位亦与OS较差(HR 1.319)和PFS较差(HR 1.282)相关。相较于基线疼痛,动态评估疼痛具有更优的预测能力。
要点
- 当前WPS每增加1单位与OS较差(HR 1.316)和PFS较差(HR 1.319)相关。
- 当前PIS每增加1单位与OS较差(HR 1.319)和PFS较差(HR 1.282)相关。
- 相较于基线疼痛,动态评估疼痛具有更优的预测能力。
核心结论
- 患者报告疼痛与mCSPC的OS和PFS之间存在潜在的动态相互作用。
- 相较于基线疼痛,动态评估疼痛具有更优的预测能力,有潜力在初始治疗反应基础上指导后续治疗。
研究设计与样本
- LATITUDEⅢ期随机研究的探索性分析,纳入新发mCSPC男性患者,随机接受ADT联合阿比特龙或单用ADT。
- 共1125例至少完成3次疼痛评分测量的患者纳入分析,疼痛评分采用简明疼痛评估量表-简表(BPI-SF)的患者报告最重疼痛评分(WPS)和疼痛干扰评分(PIS)。
- 采用贝叶斯联合建模方法分析WPS和PIS的动态变化与OS及PFS的关联。
主要发现
- Cox多变量回归中,基线WPS升高与OS较差相关(HR 1.049 [95%CI 1.015-1.085];时间依赖AUC 0.64),与PFS较差相关(HR 1.045 [95%CI 1.011-1.080];tAUC 0.64)。
- 基线PIS升高与OS较差相关(HR 1.062 [95%CI 1.020-1.105];tAUC 0.63),但与PFS无显著关联(HR 1.038 [95%CI 0.996-1.08])。
- 独立联合模型中,当前WPS值每增加1单位与OS较差相关(HR 1.316 [95%CI 1.258-1.376];tAUC 0.74),与PFS较差相关(HR 1.319 [95%CI 1.260-1.382];tAUC 0.70)。
- 当前PIS值每增加1单位与OS较差相关(HR 1.319 [95%CI 1.261-1.381];tAUC 0.73),与PFS较差相关(HR 1.282 [95%CI 1.224-1.344];tAUC 0.73)。
临床怎么用
- 原文结论指出,动态评估疼痛具有更优的预测能力,有潜力在初始治疗反应基础上指导后续治疗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pain is an important dimension of quality-of-life in patients with metastatic castrate-sensitive prostate cancer (mCSPC). However, it is unclear if dynamic change in pain over time can predict for overall survival (OS) or progression-free survival (PFS) in these patients. METHODS: This is an exploratory analysis of LATITUDE, a phase III randomized study, in which men with de novo mCSPC were randomized to receive either ADT plus abiraterone versus ADT alone. Information was collected on patient-reported worst pain score (WPS) and pain-interference score (PIS) from the Brief Pain Inventory-Short Form. A Bayesian joint modelling approach was used determine the association of dynamic change in WPS and PIS with OS and PFS. RESULTS: Overall, 1125 patients with at least 3 measurements on pain scores were eligible. On Cox multivariable regression, increase in baseline WPS was associated with inferior OS (hazard ratio [HR] 1.049 [95% confidence intervals [CI] 1.015-1.085]; time dependent area under curve [tAUC] 0.64) and PFS (HR 1.045 [1.011-1.080]; tAUC: 0.64). Increase in baseline PIS was associated with inferior OS (HR 1.062 [1.020-1.105]; tAUC: 0.63) but not with PFS (HR 1.038 [0.996-1.08]). On independent joint models, an increase in the current value of WPS by 1-unit was associated with inferior OS (HR 1.316 [1.258-1.376]; tAUC 0.74) and PFS (HR 1.319 [1.260-1.382]; tAUC 0.70). Similar association was seen for increase in the current value of PIS with OS (HR 1.319 [1.261-1.381]; tAUC 0.73) and PFS (HR 1.282 [1.224-1.344]; tAUC 0.73). CONCLUSIONS: The above findings highlight the potential dynamic interplay between patient-reported pain with OS and PFS in mCSPC. Compared to baseline pain, such dynamic assessment of pain was found to have superior predictive ability and thus has the potential to tailor subsequent treatment based on response to initial therapy beyond its role as a very important dimension of quality-of-life.
引用
- Roy S, Morgan SC, Wallis CJD, et al. Association of dynamic change in patient-reported pain with survival in metastatic castrate sensitive prostate cancer-exploratory analysis of LATITUDE study. Prostate Cancer Prostatic Dis. 2022. PMID: 36097167. doi:10.1038/s41391-022-00529-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。